Where China’s AI models really make money

Where China’s AI models make their money

Unlike overseas rivals that rely on subscriptions and APIs, Chinese AI vendors are monetizing through cloud platforms, project contracts and compute usage    By LeadLeo Research Institute As commercialization of…
Kinwong is making an IPO

BRIEF: InSilico jumps in Hong Kong trading debut

Shares of AI-driven drug discovery platform InSilico Medicine (3696.HK) opened up 45% at HK$35 in their Hong Kong trading debut on Tuesday, before paring the gains to close up 34.1%…